LEADER 01107nam0-22003491i-450- 001 990002022260403321 005 20090410104311.0 035 $a000202226 035 $aFED01000202226 035 $a(Aleph)000202226FED01 035 $a000202226 100 $a20030910g19121937km-y0itay50------ba 101 0 $aeng 200 1 $aExotic microlepidoptera$fEdward Meyrick 210 $aLondon$cTaylor & Francis$d1912-1937 215 $a5 vols.$d22 cm 314 $aPrefazione e indici al vol. 5 di J. F. Gates Clarke 327 1 $a1.: 640 p. / 1912-1916$a2.: 640 p. / 1916-1923$a3.: 640 p. / 1923-1930$a4.: 642 p. / 1930-1936$a5.: 160 p. / 1936-1937 610 0 $aLepidotteri Esotici 610 0 $aMicrolepidotteri 676 $a595.78 700 1$aMeyrick,$bEdward$085769 702 1$aClarke,$bJohn Frederick Gates 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990002022260403321 952 $a61 IV G.7/127-130(v.1-4)$b470$fDAGEN 952 $a61 V E.8/30(v.5)$b470$fDAGEN 959 $aDAGEN 959 $aDAGEN 996 $aExotic microlepidoptera$9405250 997 $aUNINA LEADER 03702nam 2200637Ia 450 001 9910961539303321 005 20251116181554.0 010 $a1-60876-728-0 035 $a(CKB)2550000001041394 035 $a(EBL)3018574 035 $a(SSID)ssj0000852621 035 $a(PQKBManifestationID)12421877 035 $a(PQKBTitleCode)TC0000852621 035 $a(PQKBWorkID)10854100 035 $a(PQKB)11472861 035 $a(MiAaPQ)EBC3018574 035 $a(Au-PeEL)EBL3018574 035 $a(CaPaEBR)ebr10660435 035 $a(OCoLC)923658905 035 $a(BIP)27059324 035 $a(EXLCZ)992550000001041394 100 $a20090504d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aHDL and LDL cholesterol $ephysiology and clinical significance /$fIrwin S. Pagano and Nathan B. Strait, editors 205 $a1st ed. 210 $aNew York $cNova Biomedical Books$dc2009 215 $a1 online resource (242 p.) 225 1 $aBiochemistry research trends series 300 $aDescription based upon print version of record. 311 08$a1-60741-767-7 320 $aIncludes bibliographical references and index. 327 $aCost-effectiveness of pharmacological therapies to reduce LDL-cholesterol levels / Pedro Plans-Rubio? -- Mechanisms for oxidative modification of LDL by cigarette smoking : new insight into potential implications for atherosclerosis / Yu Yamaguchi, Jun Haginaka, and Masaru Kunitomo -- Selective LDL apheresis reduced on plasma concentrations of adhesion molecules / Kouichi Utsumi, Kae Ueda, and Yasuo Katayama -- Pleiotropic effects of atorvastatin on vascular injury in diabetes / Sho-ichi Yamagishi ... [et al.] -- Antibodies to oxidatively modified LDL and atherosclerosis / Ulrike Resch, Franz Tatzber -- Overview of longevity-associated mitochondrial DNA 5178 C/A polymorphism and a discussion of its modulation of the effects of habitual smoking on serum total and LDL cholesterol levels in middle-aged Japanese men / Akatsuki Kokaze ... [et al.] -- Cholesterol-HDL levels and functionality of the HDL particle, its anti-inflammatory/antioxidant properties / M. Fito? ... [et al.] -- The role of HDL-associated enzymes in bovine reproduction / Romana Turk -- HDL physicochemical characteristics as determinants of their plasma concentrations : what we have learned from thiazolidinediones / Oscar Pe?rez-Me?ndez ... [et al.] -- High-density lipoproteins and coronary heart disease HDLs : a heterogeneous and multi-functional lipoprotein class / Bela F. Asztalos and Katalin V. Horvath. 330 $aThis book focuses on ways to reduce LDL-cholesterol levels, and therefore reduce the risk of serious health problems. Other factors that affect cholesterol levels, such as cigarette smoking and diabetes, are looked at as well. 410 0$aBiochemistry research trends. 606 $aHigh density lipoproteins$xPhysiological effect 606 $aHigh density lipoproteins$xPathophysiology 606 $aLow density lipoproteins$xPhysiological effect 606 $aLow density lipoproteins$xPathophysiology 615 0$aHigh density lipoproteins$xPhysiological effect. 615 0$aHigh density lipoproteins$xPathophysiology. 615 0$aLow density lipoproteins$xPhysiological effect. 615 0$aLow density lipoproteins$xPathophysiology. 676 $a572/.68 701 $aPagano$b Irwin S$01871807 701 $aStrait$b Nathan B$01871808 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910961539303321 996 $aHDL and LDL cholesterol$94480754 997 $aUNINA